Researchers

NISHIDA Naoshi

NISHIDA Naoshi
Clinical Professor
Faculty Department of Medicine / Graduate School of Medical Sciences
Researchmap https://researchmap.jp/naoshinishida

Education and Career

Education

  • - 1985 , Osaka Medical College, Faculty of Medicine,
  • - 1993 , Kyoto University, Graduate School of Medicine,

Academic & Professional Experience

  • Apr. 2021 - Today , Kindai University Faculty of Medicine Professor
  • Aug. 2011 - Mar. 2021 , Fuculty of Medicine Kindai University Department of Gastroenterology and Hepatology Associate Professor
  • Aug. 2006 - Jul. 2011 , Kyoto University Graduate School of Medicine Department of Gastroenterology and Hepatology Assistant Professor/Lecture
  • Feb. 2004 - Jul. 2006 , Baylor University Medical Center Division of Gastroenterology Reserach Associate
  • Apr. 1997 - Jan. 2004 , Kyoto University Graduate School of Medicine Department of Medicine and Clinical Science Assistant Professor
  • May. 1996 - Apr. 1997 , Research Institute for Production Development Researcher

Research Activities

Research Areas

  • Informatics, Biological, health, and medical informatics
  • Life sciences, Genomics
  • Life sciences, Gastroenterology

Research Interests

data base, artificial Intelligence, Molecular Biology, Hepatology, Gastroenterology, Epigenetics, chromosome, tumor suppressor gene, Hepatocellular carcinoma

Published Papers

  1. Advanced machine learning outperforms clinical biomarkers for predicting clinical response in patients receiving atezolizumab plus bevacizumab for advanced hepatocellular carcinoma.
    Mathew Vithayathil; Giulia F. Manfredi; Antonio D'Alessio; Claudia Angela; Maria Fulgenzi; Ciro Celsa; Pasquale Lombardi; Aria Torkpour; Bernardo Stefanini; Peter R Galle; Naoshi Nishida; Bernhard Scheiner; Fionnuala Crowley; Meng Wu; Celina Ang; Thomas U Marron; Wei-Fan Hsu; Chun-Yen Lin; Ryan Po-Ting Lin; Susanna Ulahannan; Aleena Itani; Noha Soror; Ahmed Kaseb; Michael Lapelusa; Martin Schönlein; Johann von Felden; Kornelius Schulze; Henning Wege; Brooke Wietharn; Caterina Vivaldi; Francesca Salani; Gianluca Masi; Tiziana Pressiani; Andrea Dalbeni; Leonardo Natola; Mariarosa Marseglia; Fabio Piscaglia; Yi-Hsiang Huang; Pei-Chang Lee; Mario Pirisi; Natascha Rohlen; Robert Thimme; Marianna Silletta; Emanuela Di Giacomo; Bruno Vincenzi; Luca Galbato; Vogel; Giuseppe Cabibbo; Calogero Camma; Hong Jae Chon; Matthias Pinter; Alessio Cortellini; Masatoshi Kudo; Valentia Zanuso; Lorenza Rimassa; David J Pinato; Eric Aboagye; Rohini Sharma
    Lancet Digital Health  (in press)  2026  , Refereed
  2. Reproducible safety and efficacy of durvalumab plus tremelimumab for hepatocellular carcinoma in clinical practice: results of the DT-real study.
    Ciro Celsa; Tiziana Pressiani; Naoshi Nishida; Shadi Mohamad; Chamseddine; Ashwini Arvind; Michael Li; Marta Fortuny; Najib Ben Khaled; Massimo Iavarone; Hidenori Toyoda; Ilario Giovanni Rapposelli; Andrea Casadei-Gardini; Caterina Vivaldi; Susanna Ulahannan; Haripriya Andanamala; Bernhard Scheiner; Matthias Pinter; Elena Orlandi; Claudia A.; M. Fulgenzi; Giulia F. Manfredi; Pasquale Lombardi; Antonio D’Alessio; Bernardo Stefanini; Rosanna Villani; Francesca Romana Ponziani; Leonardo Stella; Ornella Carminati; Angela Dalia Ricci; Melina Gonzalez; Alba Sparacino; Gabriele Di Maria; Marco Vaccaro; Giuseppe Cabibbo; Calogero Cammà; Maria Reig; Robin K Kelley; Amit G. Singal; Ahmed O. Kaseb; Masatoshi Kudo; Lorenza Rimassa; David James Pinato
    JHEP Reports  (in press)  2026  , Refereed
  3. Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi-Center Real-World Study.
    Federica Lo Prinzi; Federico Rossari; Antonio De Rosa; Caterina Vivaldi; Masatoshi Kudo; Shigeo Shimose; Goki Suda; Silvia Camera; Silvia Foti; Mario Domenico Rizzato; Francesca Salani; Naoshi Nishida; Tomotake Shirono; Naoya Sakamoto; Laura Passeri; Michele Ferrara; Caterina Soldà; Silvia Cesario; Kazuomi Ueshima; Takashi Niizeki; Takuya Sho; Mara Persano; Francesco Vitiello; Federica Invernizzi; Sara Lonardi; Gianluca Masi; Margherita Rimini; Andrea Casadei Gardini
    Hepatology research : the official journal of the Japan Society of Hepatology  21, Nov. 2025 

MORE

Books etc

  1. Clinical Practice Guidelines for Hepatocellular Carcinoma , Naoshi Nishida , Tumor immune microenviroment of hepatocellular carcinoma and It's clinical implicaiton , Tumor immune microenviroment of hepatocellular carcinoma and It's clinical implicaiton , 医学書院 , Apr. 2025
  2. Clinical Practice Guidelines for Hepatocellular Carcinoma , Naoshi Nishida , Clinical Significance of genomic and epigenetic alterations in hepatocellular carcinoma , Clinical Significance of genomic and epigenetic alterations in hepatocellular carcinoma , 医学書院 , Apr. 2025
  3. Immunotherapy in Hepatocellular Carcinoma , Naoshi Nishida; Masatoshi Kudo , MDPI Books , Apr. 2023

MORE

Conference Activities & Talks

  1. Regression Model for Predicting the Glycolysis-Driven HCC Subclass , Tomoko Aoki; Naoshi Nishida; Masatoshi Kudo , JDDW2025、29th Annual Meeting of JSH, International Symposium 1 , 30, Oct. 2025
  2. Immune Landscape of Intrahepatic cholangiocarcinoma and its Clinical Implication , Naoshi Nishida , APPLE 2025; The 15th Asia-Pacific Primary Liver Cancer Expert Meeting , 13, Jul. 2025
  3. The Immune Microenvironment and Clinical Characteristics of Hepatocellular Carcinoma with Enhanced Glycolysis , Tomoko Aoki; Naoshi Nishida; Masahiro Morita; Hirokazu Chishina; Masahiro Takita; Satoshi Hagiwara; Yasunori Minami; Kazuomi Ueshima; Masatoshi Kudo , The 61st Annual Meeting of the Japan Liver Cancer Association , 10, Jul. 2025

MORE

MISC

  1. 【全領域をコンプリート! 超進化!AI時代の臨床検査】(3章)生理学的検査 腹部超音波検査 , 西田 直生志; 工藤 正俊 , 検査と技術 , 53 , 8 , 896 , 902 , Aug. 2025
  2. 原発性肝がんのゲノム診断と臨床応用:新時代への挑戦 RNA発現量を用いたHCCのTIMEシグネチャ解析 , 青木 智子; 西田 直生志; 工藤 正俊 , 肝臓 , 66 , Suppl.1 , A97 , A97 , Apr. 2025
  3. 肝疾患基礎研究from bench to bedside,未来の肝臓病学を考える(2) 肝細胞癌の代謝機能に基づいた新しい分子学的分類の提唱 , 青木 智子; 西田 直生志; 工藤 正俊 , 肝臓 , 66 , Suppl.1 , A219 , A219 , Apr. 2025

MORE

Awards & Honors

  1. Dec. 2025, Terumo Life Science Foundation, FY 2025 Medical Contribution Activity Subsidy
  2. May. 2025, AME Publishing Company, Outstanding Authors
  3. Jun. 2022, The Japan Society of Hepatology, Hepatology Research Citation Award

MORE

Research Grants & Projects

  1. Terumo Life Science Foundation, FY 2025 Medical Contribution Activity Subsidy, Multimodal AI for Early Ultrasound Detection of Liver Cancer
  2. 日本学術振興会, 科学研究費助成事業, 胆道癌のドライバー変異に着目した腫瘍免疫微小環境の再構築と治療最適化 , 近畿大学
  3. 日本学術振興会, 科学研究費助成事業, 免疫チェックポイント阻害剤投与に伴う急速な腫瘍増大(HPD)の発症機序の解析 , 近畿大学

MORE